Clinical trial
Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP
NCT06414408 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- October 18, 2024
- Completion date
- December 1, 2028
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.